Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Schizophrenia

Free Subscription Articles published in Acta Psychiatr Scand Retrieve available abstracts of 37 articles: HTML format

Single Articles

December 2025
1. FUGLSANG NFB, Madsen NM, Jacobsen SL, Frokjaer JE, et al
   Efficacy and Acceptability of Licensed and Off-Label Pharmacological Interventions for Insomnia in Patients With Severe Mental Illness: A Systematic Review and Meta-Analysis of Randomised Trials.
   Acta Psychiatr Scand. 2025;152:405-421.
   PubMed     Abstract available
   
   
   November 2025
2. 
   Correction to "Homocysteine Levels and Glucose Metabolism in Non-Obese, Non-Diabetic Chronic Schizophrenia".
   Acta Psychiatr Scand. 2025 Nov 5. doi: 10.1111/acps.70045.
   PubMed    
   
   
   
3. 
   Correction to "A Double-Blind, Placebo-Controlled Trial of Rosiglitazone for Clozapine-Induced Glucose Metabolism Impairment in Patients with Schizophrenia".
   Acta Psychiatr Scand. 2025 Nov 3. doi: 10.1111/acps.70044.
   PubMed    
   
   
   October 2025
4. HUANG MH, Cheng CM, Hsu JW, Bai YM, et al
   Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects.
   Acta Psychiatr Scand. 2025 Oct 30. doi: 10.1111/acps.70043.
   PubMed     Abstract available
   
   
   
5. ERCIS M, Miola A, Ortiz-Orendain J, Pazdernik VK, et al
   Three Distinct Pathways to First Episode Mania and Psychosis: Latent Class Analysis of Antecedent Psychopathology.
   Acta Psychiatr Scand. 2025;152:278-289.
   PubMed     Abstract available
   
   
   September 2025
6. HIERONYMUS F, Hieronymus M, Sjostedt A, Nilsson S, et al
   Predicting Remission in Schizophrenia Using Machine Learning-Assessing the Impact of Sample Size and Predictor Overinclusion.
   Acta Psychiatr Scand. 2025 Sep 10. doi: 10.1111/acps.70037.
   PubMed     Abstract available
   
   
   
7. PEYROVIAN B, Palaniyappan L, Kolivakis TT, Margolese HC, et al
   Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials.
   Acta Psychiatr Scand. 2025 Sep 4. doi: 10.1111/acps.70034.
   PubMed     Abstract available
   
   
   
8. NORMARK S, Wium-Andersen MK, Osler M, Wium-Andersen IK, et al
   Risk of Dementia in Patients Suffering From Psychosis-A Danish Register-Based Cohort Study.
   Acta Psychiatr Scand. 2025;152:180-186.
   PubMed     Abstract available
   
   
   
9. TAYLOR D, Gee S, Helthuis M, Oloyede E, et al
   The Safety of 12-Weekly Monitoring of Neutrophil Count in Long-Term Clozapine Patients.
   Acta Psychiatr Scand. 2025;152:187-192.
   PubMed     Abstract available
   
   
   August 2025
10. VAURIO O, Tiihonen J, Lahteenvuo M, Lieslehto J, et al
    Psychopathic Traits Associate With Later Schizophrenia.
    Acta Psychiatr Scand. 2025 Aug 25. doi: 10.1111/acps.70027.
    PubMed     Abstract available
    
    
    July 2025
11. XIE Y, Li C, Guan M, Zhang T, et al
    Transcriptomic and Neurotransmitter Insights Into Gray Matter Volume Changes From 1 Hz rTMS in Treating Schizophrenia With Auditory Verbal Hallucinations.
    Acta Psychiatr Scand. 2025 Jul 6. doi: 10.1111/acps.70014.
    PubMed     Abstract available
    
    
    
12. GIBSON L, Mueller C, Stewart R
    Psychosis and Dementia-Disorders of Disadvantage.
    Acta Psychiatr Scand. 2025 Jul 6. doi: 10.1111/acps.70012.
    PubMed    
    
    
    
13. SMITH RL, Andreassen OA, Kane JM, Schoretsanitis G, et al
    Correlation Between Clozapine and CRP Levels in Relation to Smoking Status.
    Acta Psychiatr Scand. 2025;152:69-76.
    PubMed     Abstract available
    
    
    June 2025
14. PER BL, Loeser S, Edwards S, Lee WS, et al
    The Impact of Metformin on Weight and Waist Circumference in Patients Treated With Clozapine: A One-Year Retrospective Cohort Study.
    Acta Psychiatr Scand. 2025;151:719-730.
    PubMed     Abstract available
    
    
    March 2025
15. DE WINTER L, Jelsma A, Vermeulen JM, Vellinga A, et al
    Interrelationships of Changes in Outcome Domains in Patients With Schizophrenia Spectrum Disorders: A Meta-Analysis.
    Acta Psychiatr Scand. 2025 Mar 30. doi: 10.1111/acps.13808.
    PubMed     Abstract available
    
    
    December 2024
16. FORTE MF, Clougher D, Segura AG, Mezquida G, et al
    From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis.
    Acta Psychiatr Scand. 2024 Dec 25. doi: 10.1111/acps.13779.
    PubMed     Abstract available
    
    
    November 2024
17. ODSBU I, Hamina A, Hjellvik V, Handal M, et al
    Initiation of Antipsychotics During the First Year After First-Episode Psychosis: A Population-Based Study.
    Acta Psychiatr Scand. 2024 Nov 29. doi: 10.1111/acps.13776.
    PubMed     Abstract available
    
    
    
18. TAHMAZOV E, Bosse J, Glemain B, Nabbe P, et al
    Impact of Early Intervention for Early Psychosis on Suicidal Behavior-A Meta-Analysis.
    Acta Psychiatr Scand. 2024 Nov 27. doi: 10.1111/acps.13773.
    PubMed     Abstract available
    
    
    
19. D'ANDREA G, Quattrone D, Tripoli G, Spinazzola E, et al
    Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study.
    Acta Psychiatr Scand. 2024 Nov 1. doi: 10.1111/acps.13767.
    PubMed     Abstract available
    
    
    October 2024
20. MADSEN NM, Sorensen MA, Danielsen AA, Hojlund M, et al
    The risk of diabetes and HbA1c deterioration during antipsychotic drug treatment: A Danish two-cohort study among patients with first-episode schizophrenia.
    Acta Psychiatr Scand. 2024 Oct 8. doi: 10.1111/acps.13760.
    PubMed     Abstract available
    
    
    September 2024
21. VAN OPSTAL DPJ, Kia SM, Jakob L, Somers M, et al
    Psychosis Prognosis Predictor: A continuous and uncertainty-aware prediction of treatment outcome in first-episode psychosis.
    Acta Psychiatr Scand. 2024 Sep 18. doi: 10.1111/acps.13754.
    PubMed     Abstract available
    
    
    
22. COHN AB, Yang YS
    The effects of individualism versus collectivism on clozapine policy stringency.
    Acta Psychiatr Scand. 2024;150:180-181.
    PubMed    
    
    
    August 2024
23. KEINANEN J, Eskelinen S, From T, Laurikainen H, et al
    Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in Finland.
    Acta Psychiatr Scand. 2024 Aug 29. doi: 10.1111/acps.13752.
    PubMed     Abstract available
    
    
    
24. LIN YP, Chen WY, Pan CH, Su SS, et al
    Age-stratified risk of suicide in patients with schizophrenia.
    Acta Psychiatr Scand. 2024 Aug 14. doi: 10.1111/acps.13747.
    PubMed     Abstract available
    
    
    
25. AMBROSEN KS, Lemvigh CK, Nielsen MO, Glenthoj BY, et al
    Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naive patients with first-episode psychosis.
    Acta Psychiatr Scand. 2024 Aug 12. doi: 10.1111/acps.13743.
    PubMed     Abstract available
    
    
    July 2024
26. SASS MR, Christensen AMB, Christensen ML, Gruber E, et al
    Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study.
    Acta Psychiatr Scand. 2024;150:35-47.
    PubMed     Abstract available
    
    
    June 2024
27. BERKHOF M, van der Stouwe ECD, Pot-Kolder RMCA, van der Gaag M, et al
    Exploring the role of clinical and demographic characteristics on the effects of virtual reality cognitive behavioral therapy for psychosis: A moderator analysis.
    Acta Psychiatr Scand. 2024 Jun 9. doi: 10.1111/acps.13713.
    PubMed     Abstract available
    
    
    April 2024
28. CLARK I, Wallman P, Gee S, Taylor D, et al
    Long term impact of 3-monthly paliperidone palmitate on hospitalisation in patients with schizophrenia: Six-year mirror image study.
    Acta Psychiatr Scand. 2024 Apr 15. doi: 10.1111/acps.13691.
    PubMed    
    
    
    
29. DALAL TC, Liang L, Silva AM, Mackinley M, et al
    Speech based natural language profile before, during and after the onset of psychosis: A cluster analysis.
    Acta Psychiatr Scand. 2024 Apr 10. doi: 10.1111/acps.13685.
    PubMed     Abstract available
    
    
    February 2024
30. BERGQVIST J, Hedskog S, Hedman C, Schultz T, et al
    Patients with both cancer and psychosis-to what extent do they receive specialized palliative care.
    Acta Psychiatr Scand. 2024 Feb 18. doi: 10.1111/acps.13666.
    PubMed     Abstract available
    
    
    
31. TSUKAHARA M, So R, Yoshimura Y, Nakajima S, et al
    Response to the letter to the Editor from Araujo and colleagues on the research article entitled, "Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year r
    Acta Psychiatr Scand. 2024 Feb 15. doi: 10.1111/acps.13674.
    PubMed    
    
    
    January 2024
32. ARAUJO MB, Nogueira GN, Silveira PLSD, de Souza Junior SA, et al
    Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment-resistant schizophrenia.
    Acta Psychiatr Scand. 2024 Jan 23. doi: 10.1111/acps.13659.
    PubMed    
    
    
    
33. DREVINSKAITE M, Kaceniene A, Patasius A, Stukas R, et al
    Cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
    Acta Psychiatr Scand. 2024 Jan 3. doi: 10.1111/acps.13651.
    PubMed     Abstract available
    
    
    December 2023
34. EDVARDSEN E, Moszkowicz M, Olsen AL, Heinrichsen M, et al
    Clinical and sociodemographic features in offspring aged 0-3 years of mothers with schizophrenia spectrum disorders. A descriptive cross-sectional study.
    Acta Psychiatr Scand. 2023 Dec 10. doi: 10.1111/acps.13641.
    PubMed     Abstract available
    
    
    
35. OLOYEDE E, Dima A, Taylor D, Cheung H, et al
    Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review.
    Acta Psychiatr Scand. 2023;148:538-552.
    PubMed     Abstract available
    
    
    November 2023
36. JOHN AP, Mya T, Haywood D
    Cognitive deficits among people with schizophrenia and prediabetes or diabetes.
    Acta Psychiatr Scand. 2023 Nov 10. doi: 10.1111/acps.13627.
    PubMed     Abstract available
    
    
    September 2023
37. TSUKAHARA M, So R, Yoshimura Y, Yamashita R, et al
    Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
    Acta Psychiatr Scand. 2023 Sep 8. doi: 10.1111/acps.13612.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.